$SNES
SenesTech, Inc. Stock $snes

$snes Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038343 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$295.0K	$360.0K
YoY Change	-0.67%	44.0%
Cost Of Revenue	$166.0K	$184.0K
YoY Change	-8.29%	43.75%
Gross Profit	$129.0K	$176.0K
YoY Change	11.21%	44.26%
Gross Profit Margin	43.73%	48.89%
Selling, General & Admin	$1.784M	$1.748M
YoY Change	-1.22%	-23.63%
% of Gross Profit	1382.95%	993.18%
Research & Development	$81.00K	$379.0K
YoY Change	-81.38%	-16.15%
% of Gross Profit	62.79%	215.34%
Depreciation & Amortization	$31.00K	$34.00K
YoY Change	-11.43%	-2.86%
% of Gross Profit	24.03%	19.32%
Operating Expenses	$1.865M	$2.127M
YoY Change	-17.7%	-22.4%
Operating Profit	-$1.736M	-$1.951M
YoY Change	-19.26%	-25.51%
Interest Expense	$3.000K	$4.000K
YoY Change	50.0%	300.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$4.000K
YoY Change		-114.81%
Pretax Income	-$1.733M	-$1.947M
YoY Change	-19.32%	-26.42%
Income Tax
% Of Pretax Income
Net Earnings	-$1.733M	-$1.947M
YoY Change	-19.32%	-26.42%
Net Earnings / Revenue	-587.46%	-540.83%
Basic Earnings Per Share		-$0.47
Diluted Earnings Per Share	-$0.90	-$0.47
COMMON SHARES
Basic Shares Outstanding	3.631M shares	2.964M shares
Diluted Shares Outstanding		4.177M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.395M	$2.145M
YoY Change	12.98%	-23.17%
Cash & Equivalents	$5.400M	$2.100M
Short-Term Investments
Other Short-Term Assets	$388.0K	$385.0K
YoY Change	2.65%	-9.62%
Inventory	$795.0K	$703.0K
Prepaid Expenses	$388.0K	$385.0K
Receivables	$95.00K	$83.00K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.673M	$3.316M
YoY Change	9.05%	-22.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$388.0K	$313.0K
YoY Change	31.97%	-2.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$22.00K	$22.00K
YoY Change	0.0%
Total Long-Term Assets	$620.0K	$552.0K
YoY Change	-6.49%	-22.36%
TOTAL ASSETS
Total Short-Term Assets	$6.673M	$3.316M
Total Long-Term Assets	$620.0K	$552.0K
Total Assets	$7.293M	$3.868M
YoY Change	7.53%	-22.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$150.0K	$147.0K
YoY Change	-72.22%	-69.12%
Accrued Expenses	$368.0K	$671.0K
YoY Change	-34.29%	-32.02%
Deferred Revenue	$18.00K	$15.00K
YoY Change	-59.09%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$33.00K	$9.000K
YoY Change
Total Short-Term Liabilities	$786.0K	$1.034M
YoY Change	-40.63%	-31.57%
LONG-TERM LIABILITIES
Long-Term Debt	$156.0K	$44.00K
YoY Change
Other Long-Term Liabilities	$0.00	$34.00K
YoY Change	-100.0%	-91.54%
Total Long-Term Liabilities	$156.0K	$78.00K
YoY Change	-12.85%	-80.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$786.0K	$1.034M
Total Long-Term Liabilities	$156.0K	$78.00K
Total Liabilities	$942.0K	$1.112M
YoY Change	-37.33%	-41.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$129.9M	-$128.2M
YoY Change	6.3%	6.78%
Common Stock	$5.000K	$3.000K
YoY Change	400.0%	-75.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.351M	$2.756M
YoY Change
Total Liabilities & Shareholders Equity	$7.293M	$3.868M
YoY Change	7.53%	-22.17%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$1.733M	-$1.947M
YoY Change	-19.32%	-26.42%
Depreciation, Depletion And Amortization	$31.00K	$34.00K
YoY Change	-11.43%	-2.86%
Cash From Operating Activities	-$2.019M	-$1.787M
YoY Change	-8.64%	-19.47%
INVESTING ACTIVITIES
Capital Expenditures	$35.00K	$94.00K
YoY Change	-10.26%	754.55%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$35.00K	-$94.00K
YoY Change	0.0%	-954.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.304M	1.831M
YoY Change	25.45%
NET CHANGE
Cash From Operating Activities	-2.019M	-1.787M
Cash From Investing Activities	-35.00K	-94.00K
Cash From Financing Activities	5.304M	1.831M
Net Change In Cash	3.250M	-50.00K
YoY Change	63.89%	-97.74%
FREE CASH FLOW
Cash From Operating Activities	-$2.019M	-$1.787M
Capital Expenditures	$35.00K	$94.00K
Free Cash Flow	-$2.054M	-$1.881M
YoY Change	-8.67%	-15.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4176592	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4176592	shares
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12000	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	22000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	34000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	179000	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	44000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q3	us-gaap	Liabilities Liabilities	1112000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1503000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	809648	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	130933000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	127481000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128180000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-122203000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2756000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5279000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3868000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6782000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	898000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	488000	usd
	us-gaap	Gross Profit GrossProfit	410000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1147000	usd
	us-gaap	Operating Expenses OperatingExpenses	6406000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5996000	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	19000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19000	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3037790	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3037790	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
	us-gaap	Net Income Loss NetIncomeLoss	-5977000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7547000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	104000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	148000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	467000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	570000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-4000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-28000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-34000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	7000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	174000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-150000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-48000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-393000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	142000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	111000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	409000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-29000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	48000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5547000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6339000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	114000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	167000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-114000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4800000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-163000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2998000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	44000	usd
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-5000	usd
	snes	Repayments Of Finance Lease Obligations RepaymentsOfFinanceLeaseObligations	0	usd
	snes	Repayments Of Finance Lease Obligations RepaymentsOfFinanceLeaseObligations	27000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3031000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2630000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6534000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4775000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9326000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2145000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2792000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q3	snes	Number Of States Registration Received NumberOfStatesRegistrationReceived	50	state
CY2023Q3	snes	Number Of States Approved Removal Of Restricted Use Designation NumberOfStatesApprovedRemovalOfRestrictedUseDesignation	49	state
CY2023Q3	snes	Number Of Major Us Territories Registration Received NumberOfMajorUSTerritoriesRegistrationReceived	5	territory
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128200000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2100000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The significant estimates in our financial statements include the valuation of inventory, common stock warrants, and stock-based awards, such as stock options and restricted stock units. Actual results could differ from such estimates.</span></div>
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-28000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	85000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	119000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	83000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	113000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	2000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	7000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	670000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	772000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	5000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	46000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	99000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	721000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	871000	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	18000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	703000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	853000	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	497000	usd
CY2023Q3	snes	Inventory Valuation Reserves Additions InventoryValuationReservesAdditions	0	usd
CY2022Q3	snes	Inventory Valuation Reserves Additions InventoryValuationReservesAdditions	0	usd
CY2023Q3	snes	Inventory Valuation Reserves Amount Relieved InventoryValuationReservesAmountRelieved	0	usd
CY2022Q3	snes	Inventory Valuation Reserves Amount Relieved InventoryValuationReservesAmountRelieved	3000	usd
CY2023Q3	snes	Prepaid Software Licenses Current PrepaidSoftwareLicensesCurrent	138000	usd
CY2022Q4	snes	Prepaid Software Licenses Current PrepaidSoftwareLicensesCurrent	157000	usd
CY2023Q3	snes	Professional Services Retainer ProfessionalServicesRetainer	95000	usd
CY2022Q4	snes	Professional Services Retainer ProfessionalServicesRetainer	41000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	44000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	61000	usd
CY2023Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	17000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	39000	usd
CY2023Q3	snes	Marketing Programs And Conferences MarketingProgramsAndConferences	6000	usd
CY2022Q4	snes	Marketing Programs And Conferences MarketingProgramsAndConferences	74000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	85000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	6000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	385000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	378000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2387000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2283000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	313000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	294000	usd
CY2023Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	521000	usd
CY2023Q3	snes	Legal Services Current LegalServicesCurrent	135000	usd
CY2022Q4	snes	Legal Services Current LegalServicesCurrent	36000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	15000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	18000	usd
CY2023Q3	snes	Personal Property And Franchise Tax PersonalPropertyAndFranchiseTax	0	usd
CY2022Q4	snes	Personal Property And Franchise Tax PersonalPropertyAndFranchiseTax	6000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	671000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	560000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	55000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	55000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	166000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	167000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	27000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	usd
CY2023Q3	snes	Finance Lease Cost FinanceLeaseCost	0	usd
CY2022Q3	snes	Finance Lease Cost FinanceLeaseCost	0	usd
	snes	Finance Lease Cost FinanceLeaseCost	0	usd
	snes	Finance Lease Cost FinanceLeaseCost	28000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	50000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	186000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	236000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	226000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	479426	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.11
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30750	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.25
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	448676	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.34
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	280810	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.00
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	199421	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
	snes	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P5Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	31183	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	372	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	680.87
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	448676	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.34
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M12D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	194878	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	30.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	140000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	467000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	570000	usd
CY2023Q3	snes	Approved Sale Of Stock Maximum Consideration To Be Received On Transaction ApprovedSaleOfStockMaximumConsiderationToBeReceivedOnTransaction	7500000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5279000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	166000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-11000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2037000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3497000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1210000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1993000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2827000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	88000	usd
CY2023Q3	snes	Stock Issued During Period Value Warrants Modified StockIssuedDuringPeriodValueWarrantsModified	657000	usd
CY2023Q3	snes	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1131000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10035000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	221000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2332000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	7927000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	205000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2569000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5564000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	139000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2646000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3057000	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	54466	shares
	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	13225	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4414810	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6.58
CY2022	snes	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P3Y
	snes	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	6937311	shares
CY2023Q3	snes	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued	0.88
	snes	Class Of Warrant Or Right Issued Weighted Average Remaining Contractual Term ClassOfWarrantOrRightIssuedWeightedAverageRemainingContractualTerm	P4Y10M24D
	snes	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	4164575	shares
CY2023Q3	snes	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised	1.54
	snes	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	13629	shares
CY2023Q3	snes	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired	527.05
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7173917	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.00
	snes	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P4Y10M24D
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	259380	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3320332	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10170	shares
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
snes-20230930_cal.xml	Edgar Link	unprocessable
0001628280-23-038343-index-headers.html	Edgar Link	pending
0001628280-23-038343-index.html	Edgar Link	pending
0001628280-23-038343.txt	Edgar Link	pending
0001628280-23-038343-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
snes-20230930.htm	Edgar Link	pending
snes-20230930.xsd	Edgar Link	pending
snes-20230930xex311.htm	Edgar Link	pending
snes-20230930xex312.htm	Edgar Link	pending
snes-20230930xex321.htm	Edgar Link	pending
snes-20230930xex322.htm	Edgar Link	pending
snes-20230930_def.xml	Edgar Link	unprocessable
snes-20230930_lab.xml	Edgar Link	unprocessable
snes-20230930_pre.xml	Edgar Link	unprocessable
snes-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SNES
SenesTech, Inc. Stock $snes

2023 Q4 Form 10-Q Financial Statement

#000162828023038343 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNES SenesTech, Inc. Stock $snes

2023 Q4 Form 10-Q Financial Statement

#000162828023038343 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SNES
SenesTech, Inc. Stock $snes